TY - JOUR TI - Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment AU - Shan, Zhao AU - Li, Leike AU - Atkins, Constance Lynn AU - Wang, Meng AU - Wen, Yankai AU - Jeong, Jongmin AU - Moreno, Nicolas F AU - Feng, Dechun AU - Gui, Xun AU - Zhang, Ningyan AU - Lee, Chun Geun AU - Elias, Jack A AU - Lee, William M AU - Gao, Bin AU - Lam, Fong Wilson AU - An, Zhiqiang AU - Ju, Cynthia A2 - Noble, Paul W A2 - Ding, Wenxing VL - 10 PY - 2021 DA - 2021/06/10 SP - e68571 C1 - eLife 2021;10:e68571 DO - 10.7554/eLife.68571 UR - https://doi.org/10.7554/eLife.68571 AB - Background:. Hepatic platelet accumulation contributes to acetaminophen (APAP)-induced liver injury (AILI). However, little is known about the molecular pathways involved in platelet recruitment to the liver and whether targeting such pathways could attenuate AILI. Methods:. Mice were fasted overnight before intraperitoneally (i.p.) injected with APAP at a dose of 210 mg/kg for male mice and 325 mg/kg for female mice. Platelets adherent to Kupffer cells were determined in both mice and patients overdosed with APAP. The impact of α-chitinase 3-like-1 (α-Chi3l1) on alleviation of AILI was determined in a therapeutic setting, and liver injury was analyzed. Results:. The present study unveiled a critical role of Chi3l1 in hepatic platelet recruitment during AILI. Increased Chi3l1 and platelets in the liver were observed in patients and mice overdosed with APAP. Compared to wild-type (WT) mice, Chil1-/- mice developed attenuated AILI with markedly reduced hepatic platelet accumulation. Mechanistic studies revealed that Chi3l1 signaled through CD44 on macrophages to induce podoplanin expression, which mediated platelet recruitment through C-type lectin-like receptor 2. Moreover, APAP treatment of Cd44-/- mice resulted in much lower numbers of hepatic platelets and liver injury than WT mice, a phenotype similar to that in Chil1-/- mice. Recombinant Chi3l1 could restore hepatic platelet accumulation and AILI in Chil1-/- mice, but not in Cd44-/- mice. Importantly, we generated anti-Chi3l1 monoclonal antibodies and demonstrated that they could effectively inhibit hepatic platelet accumulation and AILI. Conclusions:. We uncovered the Chi3l1/CD44 axis as a critical pathway mediating APAP-induced hepatic platelet recruitment and tissue injury. We demonstrated the feasibility and potential of targeting Chi3l1 to treat AILI. Funding:. ZS received funding from NSFC (32071129). FWL received funding from NIH (GM123261). ALFSG received funding from NIDDK (DK 058369). ZA received funding from CPRIT (RP150551 and RP190561) and the Welch Foundation (AU-0042–20030616). CJ received funding from NIH (DK122708, DK109574, DK121330, and DK122796) and support from a University of Texas System Translational STARs award. Portions of this work were supported with resources and the use of facilities of the Michael E. DeBakey VA Medical Center and funding from Department of Veterans Affairs I01 BX002551 (Equipment, Personnel, Supplies). The contents do not represent the views of the US Department of Veterans Affairs or the US Government. KW - drug-induced liver injury KW - platelets KW - kupffer cells KW - chi3l1 KW - acetaminophen JF - eLife SN - 2050-084X PB - eLife Sciences Publications, Ltd ER -